Recommending flavanols and procyanidins for cardiovascular health: Current knowledge and future needs

Hagen Schroeter, Christian Heiss, Jeremy P E Spencer, Carl L Keen, Joanne R. Lupton, Harold H. Schmitz

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Data on the potential health benefits of dietary flavanols and procyanidins, especially in the context of cardiovascular health, are considerable and continue to accumulate. Significant progress has been made in flavanol analytics and the creation of phytonutrient-content food databases, and novel data emanated from epidemiological investigations as well as dietary intervention studies. However, a comprehensive understanding of the pharmacological properties of flavanols and procyanidins, including their precise mechanisms of action in vivo, and a conclusive, consensus-based accreditation of a causal relationship between intake and health benefits in the context of primary and secondary cardiovascular disease prevention is still outstanding. Thus, the objective of this review is to identify and discuss key questions and gaps that will need to be addressed in order to conclusively demonstrate whether or not dietary flavanols and procyanidins have a role in preventing, delaying the onset of, or treating cardiovascular diseases, and thus improving human life expectancy and quality of life.

Original languageEnglish (US)
Pages (from-to)546-557
Number of pages12
JournalMolecular Aspects of Medicine
Volume31
Issue number6
DOIs
StatePublished - Dec 2010

Fingerprint

Proanthocyanidins
Health
Insurance Benefits
Cardiovascular Diseases
Quality of Life
Accreditation
Phytochemicals
Life Expectancy
Databases
Pharmacology
Food

Keywords

  • Cardiovascular disease
  • Cocoa
  • Diet
  • Epicatechin
  • Nutrition
  • Phytonutrient
  • Proanthocyanidins
  • Tea

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Clinical Biochemistry
  • Medicine(all)

Cite this

Schroeter, H., Heiss, C., Spencer, J. P. E., Keen, C. L., Lupton, J. R., & Schmitz, H. H. (2010). Recommending flavanols and procyanidins for cardiovascular health: Current knowledge and future needs. Molecular Aspects of Medicine, 31(6), 546-557. https://doi.org/10.1016/j.mam.2010.09.008

Recommending flavanols and procyanidins for cardiovascular health : Current knowledge and future needs. / Schroeter, Hagen; Heiss, Christian; Spencer, Jeremy P E; Keen, Carl L; Lupton, Joanne R.; Schmitz, Harold H.

In: Molecular Aspects of Medicine, Vol. 31, No. 6, 12.2010, p. 546-557.

Research output: Contribution to journalArticle

Schroeter, H, Heiss, C, Spencer, JPE, Keen, CL, Lupton, JR & Schmitz, HH 2010, 'Recommending flavanols and procyanidins for cardiovascular health: Current knowledge and future needs', Molecular Aspects of Medicine, vol. 31, no. 6, pp. 546-557. https://doi.org/10.1016/j.mam.2010.09.008
Schroeter, Hagen ; Heiss, Christian ; Spencer, Jeremy P E ; Keen, Carl L ; Lupton, Joanne R. ; Schmitz, Harold H. / Recommending flavanols and procyanidins for cardiovascular health : Current knowledge and future needs. In: Molecular Aspects of Medicine. 2010 ; Vol. 31, No. 6. pp. 546-557.
@article{302bfa153d3a4d26b361cb8d0734d51a,
title = "Recommending flavanols and procyanidins for cardiovascular health: Current knowledge and future needs",
abstract = "Data on the potential health benefits of dietary flavanols and procyanidins, especially in the context of cardiovascular health, are considerable and continue to accumulate. Significant progress has been made in flavanol analytics and the creation of phytonutrient-content food databases, and novel data emanated from epidemiological investigations as well as dietary intervention studies. However, a comprehensive understanding of the pharmacological properties of flavanols and procyanidins, including their precise mechanisms of action in vivo, and a conclusive, consensus-based accreditation of a causal relationship between intake and health benefits in the context of primary and secondary cardiovascular disease prevention is still outstanding. Thus, the objective of this review is to identify and discuss key questions and gaps that will need to be addressed in order to conclusively demonstrate whether or not dietary flavanols and procyanidins have a role in preventing, delaying the onset of, or treating cardiovascular diseases, and thus improving human life expectancy and quality of life.",
keywords = "Cardiovascular disease, Cocoa, Diet, Epicatechin, Nutrition, Phytonutrient, Proanthocyanidins, Tea",
author = "Hagen Schroeter and Christian Heiss and Spencer, {Jeremy P E} and Keen, {Carl L} and Lupton, {Joanne R.} and Schmitz, {Harold H.}",
year = "2010",
month = "12",
doi = "10.1016/j.mam.2010.09.008",
language = "English (US)",
volume = "31",
pages = "546--557",
journal = "Molecular Aspects of Medicine",
issn = "0098-2997",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Recommending flavanols and procyanidins for cardiovascular health

T2 - Current knowledge and future needs

AU - Schroeter, Hagen

AU - Heiss, Christian

AU - Spencer, Jeremy P E

AU - Keen, Carl L

AU - Lupton, Joanne R.

AU - Schmitz, Harold H.

PY - 2010/12

Y1 - 2010/12

N2 - Data on the potential health benefits of dietary flavanols and procyanidins, especially in the context of cardiovascular health, are considerable and continue to accumulate. Significant progress has been made in flavanol analytics and the creation of phytonutrient-content food databases, and novel data emanated from epidemiological investigations as well as dietary intervention studies. However, a comprehensive understanding of the pharmacological properties of flavanols and procyanidins, including their precise mechanisms of action in vivo, and a conclusive, consensus-based accreditation of a causal relationship between intake and health benefits in the context of primary and secondary cardiovascular disease prevention is still outstanding. Thus, the objective of this review is to identify and discuss key questions and gaps that will need to be addressed in order to conclusively demonstrate whether or not dietary flavanols and procyanidins have a role in preventing, delaying the onset of, or treating cardiovascular diseases, and thus improving human life expectancy and quality of life.

AB - Data on the potential health benefits of dietary flavanols and procyanidins, especially in the context of cardiovascular health, are considerable and continue to accumulate. Significant progress has been made in flavanol analytics and the creation of phytonutrient-content food databases, and novel data emanated from epidemiological investigations as well as dietary intervention studies. However, a comprehensive understanding of the pharmacological properties of flavanols and procyanidins, including their precise mechanisms of action in vivo, and a conclusive, consensus-based accreditation of a causal relationship between intake and health benefits in the context of primary and secondary cardiovascular disease prevention is still outstanding. Thus, the objective of this review is to identify and discuss key questions and gaps that will need to be addressed in order to conclusively demonstrate whether or not dietary flavanols and procyanidins have a role in preventing, delaying the onset of, or treating cardiovascular diseases, and thus improving human life expectancy and quality of life.

KW - Cardiovascular disease

KW - Cocoa

KW - Diet

KW - Epicatechin

KW - Nutrition

KW - Phytonutrient

KW - Proanthocyanidins

KW - Tea

UR - http://www.scopus.com/inward/record.url?scp=78649631404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649631404&partnerID=8YFLogxK

U2 - 10.1016/j.mam.2010.09.008

DO - 10.1016/j.mam.2010.09.008

M3 - Article

C2 - 20854838

AN - SCOPUS:78649631404

VL - 31

SP - 546

EP - 557

JO - Molecular Aspects of Medicine

JF - Molecular Aspects of Medicine

SN - 0098-2997

IS - 6

ER -